Dr. John N. Cefalu, MD

  • Shreveport, LA
  • Interventional pain medicine physician
NPI1659804979PAC ID0749559300
Medicare services, 2024
8,711
Medicare patients, 2024
230
Part D claims, 2024
1,353
Publications
6
MIPS score, 2024
82
Practice address
510 East Stoner Avenue, Shreveport, LA 71101
Practice phone
Call (318) 424-6037
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Cefalu's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. John N. Cefalu is an interventional pain medicine physician in Shreveport, Louisiana

Dr. Cefalu practices at Overton Brooks Veterans' Administration Medical Center in Shreveport, Louisiana, part of Veterans Health Administration.

Dr. Cefalu's NPI, 1659804979, was assigned on April 4, 2017. Dr. Cefalu graduated from Louisiana State University School of Medicine in 2017. Dr. Cefalu holds Florida license ME157022.

NPI and contact details
Medicare PAC ID
0749559300
NPI enumeration date
April 4, 2017
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(318) 424-6037
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
35
Medical school graduation
2017

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. John N. Cefalu practices at Overton Brooks Veterans' Administration Medical Center in Shreveport, Louisiana

Dr. Cefalu's primary practice is Overton Brooks Veterans' Administration Medical Center, at 510 East Stoner Avenue, Shreveport, LA 71101 in Caddo Parish. The practice phone is (318) 424-6037.

Source: Dmand AI Affiliation Data

Dr. John N. Cefalu is affiliated with 8 sites of care and 4 medical groups

Dr. Cefalu's primary practice is Overton Brooks Veterans' Administration Medical Center in Shreveport, Louisiana, part of Veterans Health Administration. Dr. Cefalu is also affiliated with Willis Knighton North. The medical group on file is River Cities Interventional Pain Specialists. Dmand AI also links Dr. Cefalu to 4 more hospitals, 3 medical groups, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

See all 12 affiliations for Dr. Cefalu

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. John N. Cefalu's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cefalu practices, 8 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Overton Brooks Veterans' Administration Medical CenterAvailable with a free account
+7 more sites and 3 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Cefalu practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Veterans Health Administration and 6.2K+ hospitals, with verified contacts in the same login.

Dr. John N. Cefalu is one of 56 interventional pain medicine physicians in Louisiana

Interventional pain medicine is Dr. Cefalu's primary specialty in the NPI Registry, under taxonomy code 208VP0014X. Dr. Cefalu is licensed in Florida.

Specialties and state licenses

  • Interventional pain medicine, FloridaPrimaryLicense ME157022 · taxonomy 208VP0014X

Clinical focus

Dmand AI lists back pain injection, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal stenosis and thoracic spine disorders among the conditions Dr. Cefalu treats.

Interventional pain medicine physicians near Dr. Cefalu

Counts of interventional pain medicine physicians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. John N. Cefalu billed Medicare for 8,711 services in 2024

CMS data shows 8,711 Medicare services from Dr. Cefalu across 23 procedure codes in 2024, for 230 Medicare patients. Medicare paid $195,914 for them.

Medicare services, 20248,711
Medicare patients230
Paid by Medicare$195,914
Procedure codes23

Dr. Cefalu's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 2,2302024: 7,533238%
Surgery
2023: 4662024: 63336%
Office and hospital visits
2023: 3732024: 29321%
Other services
2023: 02024: 123
Lab and pathology
2023: 152024: 107613%
Imaging
2023: 02024: 22

Where Dr. Cefalu's Medicare services took place, 2024

  • In an office8,692100%
  • In a facility190%

Dr. Cefalu compared with the Louisiana median for interventional pain medicine physicians, 2024

  • Dr. Cefalu
  • Louisiana median
Medicare services
8,711vs 1,2187.2 times
Medicare patients
230vs 20114% above
Part D claims
1,317vs 2,91255% below

Medians across 56 interventional pain medicine physicians in Louisiana with Dmand AI profiles that report each measure.

Dr. Cefalu's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Cefalu

Need commercial claims for Dr. Cefalu?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Cefalu and other interventional pain medicine physicians in Louisiana.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. John N. Cefalu treated 230 Medicare patients in 2024, average age 74

CMS counts 230 Medicare patients who saw Dr. Cefalu in 2024. The largest group is 75 to 84, with 89 patients. 75% of them have arthritis, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cefalu's median patient age at 66, with 59% women.

Medicare patients, 2024230
Average age74
Average risk score1.32
Also on Medicaid16%

Dr. Cefalu's Medicare patients by age, 2024

Dr. Cefalu's Medicare patients by sex, 2024

  • Women13257%
  • Men9843%

Chronic conditions among Dr. Cefalu's Medicare patients, 2024

  1. Arthritis75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Diabetes41%
  5. Anxiety38%
  6. Mood disorders32%
  7. Ischemic heart disease31%
  8. Depression30%

Share of Medicare patients with each condition. A patient can have several.

Dr. Cefalu's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 66

Patient panel by sex, all payers

  • Women59%
  • Men39%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. John N. Cefalu wrote 1,353 Medicare Part D claims in 2024

In 2024, Dr. Cefalu wrote 1,353 Medicare Part D claims for 371 patients. 99% of them were for generic drugs. CMS names the drug for 1,317 of them, across 17 drugs with 11 or more claims each, at $19,321 in total drug cost. In 2023, CMS named 1,069 claims across 16 drugs.

Part D claims, 20241,353
Drugs named by CMS17
Total drug cost$19,321
Part D patients371

Dr. Cefalu's Part D claims by kind of drug, 2024

  • Generic1,337 claims99%
  • Brand-name16 claims1%

Dr. Cefalu's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Cefalu's Part D claims, 2024

  • Opioids37%502 of 1,353 claims
  • Antibiotics7%99 of 1,353 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,0692024: 1,31723%

Drugs named by CMS: 17 in 2024, 16 in 2023.

See all prescribing by Dr. Cefalu

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. John N. Cefalu scored 82 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Cefalu for performance year 2024, reported as part of a group. Dr. Cefalu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Cefalu's MIPS scores, performance year 2024

  • 82of 100Final score
  • 77.7of 100Quality
  • 95of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 66of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find interventional pain medicine physicians like Dr. Cefalu by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. John N. Cefalu has 6 publications on record

Dmand AI links 6 papers to Dr. Cefalu, published from 2017 to 2020. The most frequent topics are Anesthetics, Local. Dr. Cefalu has published most often in Curr Pain Headache Rep. Dr. Cefalu's most frequent co-authors are Alan D. Kaye, MD, Tejas Vijay Joshi, MD and Ken Philip Ehrhardt.

Papers6
Years published2017 to 2020

Dr. Cefalu's papers by year, 2017 to 2020

Topics Dr. Cefalu writes about most

  • Anesthetics, Local

Dr. Cefalu's most frequent co-authors

Recent publications by Dr. Cefalu

See all 6 publications and co-authors

See who Dr. Cefalu researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Cefalu works with, so you can find a warm path to the right interventional pain medicine physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. John N. Cefalu received $70,612 in industry payments from 2021 to 2025

CMS Open Payments shows 337 general payments to Dr. Cefalu from 26 drug and device companies from 2021 to 2025. Grants make up the largest share, 71% of the total. Boston Scientific Corporation paid the most, $39,894.

General payments to Dr. Cefalu by program year, 2021 to 2025

General payments to Dr. Cefalu by kind, 2021 to 2025

$70.6Kin total
  • Grants$50,00071%
  • Food and beverage$12,85918%
  • Travel and lodging$7,68911%
  • Education$640%

Companies that paid Dr. Cefalu the most, 2021 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Cefalu

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. John N. Cefalu graduated from Louisiana State University School of Medicine

Dr. Cefalu graduated from Louisiana State University School of Medicine in 2017.

  1. Medical schoolLouisiana State University School of Medicine

Source: Dmand AI Professional Profile Data

Dr. John N. Cefalu accepts plans from 18 insurance carriers

Dr. Cefalu is in network with 18 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.

  • Elevance
  • Aetna
  • Blue Cross Blue Shield of Michigan
  • United Healthcare
  • HCSC
  • Humana
  • Aspirus Health Plan
  • Blue Cross Blue Shield of Massachusetts
  • +10 more carriersWith a free account

Plan types Dr. Cefalu accepts, by number of carriers

  1. PPO11
  2. Medicare9
  3. HMO8
  4. POS6
  5. EPO4
  6. Medicaid2

Source: Dmand AI Insurance Network Data

Sources for Dr. John N. Cefalu's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. John N. Cefalu

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. John N. Cefalu's NPI number?

Dr. John N. Cefalu's NPI number is 1659804979. It was assigned on April 4, 2017, and it is active in the NPI Registry.

What kind of doctor is Dr. John N. Cefalu?

Dr. John N. Cefalu is an interventional pain medicine physician in Shreveport, Louisiana. The primary specialty in the NPI Registry is Interventional Pain Medicine Physician (taxonomy code 208VP0014X).

Where does Dr. John N. Cefalu practice?

Dr. Cefalu practices at 510 East Stoner Avenue, Shreveport, LA 71101. Dr. Cefalu's primary practice is Overton Brooks Veterans' Administration Medical Center in Shreveport, Louisiana, part of Veterans Health Administration. Dmand AI also links Dr. Cefalu to 4 hospitals, 3 medical groups, 1 group practice or clinic and 1 ambulatory surgery center.

What is Dr. John N. Cefalu's office phone number?

The practice phone on file for Dr. Cefalu is (318) 424-6037.

What is Dr. John N. Cefalu's medical license number?

Dr. Cefalu holds Florida license ME157022.

Which hospitals is Dr. John N. Cefalu affiliated with?

Dr. Cefalu practices at Overton Brooks Veterans' Administration Medical Center in Shreveport, Louisiana. Dr. Cefalu is also affiliated with Willis Knighton North. Dmand AI links Dr. Cefalu to 4 more hospitals.

What medical group is Dr. John N. Cefalu part of?

Dr. Cefalu is linked to River Cities Interventional Pain Specialists. Dmand AI links Dr. Cefalu to 3 more medical groups.

Does Dr. John N. Cefalu accept Medicare?

Yes. CMS data shows Dr. Cefalu billed Medicare for 8,711 services in 2024, and Dr. Cefalu accepts Medicare assignment.

What is Dr. John N. Cefalu's MIPS score?

Dr. Cefalu's MIPS final score for performance year 2024 is 82 out of 100, reported as part of a group.

How many Medicare patients does Dr. John N. Cefalu see?

CMS counts 230 Medicare patients who saw Dr. Cefalu in 2024, with an average age of 74.

Show 8 more questionsShow fewer questions

What services does Dr. John N. Cefalu bill to Medicare?

In 2024, Dr. Cefalu's most billed Medicare services were injected or infused drug (J1010), injected or infused drug (J1100) and surgery: brain, spine and nerves (64483).

Where did Dr. John N. Cefalu go to medical school?

Dr. Cefalu graduated from Louisiana State University School of Medicine in 2017.

What drugs does Dr. John N. Cefalu prescribe most?

In 2024 Medicare Part D data, Dr. Cefalu's most prescribed drugs by claims were Hydrocodone-Acetaminophen, Gabapentin and Pregabalin.

Has Dr. John N. Cefalu received payments from drug or device companies?

CMS Open Payments shows $70,612 in general payments to Dr. Cefalu from 26 companies from 2021 to 2025. The largest total came from Boston Scientific Corporation.

How long has Dr. John N. Cefalu been practicing?

Dr. Cefalu graduated from medical school in 2017, 9 years ago.

Does Dr. John N. Cefalu do research?

Dmand AI links 6 publications to Dr. Cefalu, published from 2017 to 2020.

Who does Dr. John N. Cefalu publish with?

Dr. Cefalu's most frequent co-authors are Alan D. Kaye, MD (4 shared papers), Tejas Vijay Joshi, MD (2 shared papers) and Ken Philip Ehrhardt (1 shared paper).

What insurance does Dr. John N. Cefalu accept?

Dr. Cefalu is in network with 18 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.

Selling to interventional pain medicine practices?

See interventional pain medicine physicians in Louisiana by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)